ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselCimeio Therapeutics AG
Cimeio Therapeutics AG Logo
Verified· 2 sources

Cimeio Therapeutics AG

Summary

About the company

Cimeio Therapeutics AG develops Shielded Cell & Immunotherapy Pairs™, combining paired immunotherapies with cell‑shielding gene editing to treat hematologic disorders. The platform edits cell surface receptors in hematopoietic stem cells to preserve function while preventing depletion by antibodies, ADCs, CAR‑T cells and T‑cell engagers.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Shielded-Cell & Immunotherapy Pairs™ (SCIP)
Novel immunotherapies with paired, modified cell-surface protein variants in HSCs; designed to preserve healthy cells while depleting diseased cells and supporting treatment of hematologic diseases.
Cell Shielding
Gene-editing technology that inserts novel protein variants into HSCs or other cells, preserving cell function while making them resistant to depletion by paired immunotherapies.
Therapeutics for hematologic disorders
Development of curative therapies for hematologic disorders, including hematologic malignancies, autoimmune disorders, and genetic diseases, using shielded cells and paired immunotherapies.
Comparisons

Cimeio Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cimeio Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cimeio Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60f
4057 Basel

At a glance

Legal form
Corporation
UID
CHE-465.367.689
Founded
2020 · 6 years
Last commercial register change
July 29, 2026
Employees
21 to 50

Knowledge

No knowledge articles yet

Once Cimeio Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

VA
Versameb AG
Basel
FA
FimmCyte AG
Basel
VA
Vaximm AG
Basel
MS
Moderna Switzerland GmbH
Basel
RG
RXcel GmbH
Basel
RS
Regeneron Switzerland GmbH
Basel
CA
Celonic AG
Basel
BS
BioNTech Switzerland GmbH
Basel